Maze Therapeutics, Inc. - Common Stock, par value $0.001 (MAZE)

Historical Holders from Q1 2025 to Q3 2025

Symbol
MAZE on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001
Shares outstanding
43,496,286
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
42,970,633
Holdings value
$1,114,223,528
% of all portfolios
0.009%
Number of holders
93
Number of buys
61
Number of sells
-18
Average buys %
+0%
Average sells %
-0.01%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Maze Therapeutics, Inc. - Common Stock, par value $0.001 (MAZE)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Third Rock Ventures IV, L.P. 13.9% $53,390,091 6,073,958 Third Rock Ventures IV, L.P. 31 Jan 2025
ARCH Venture Fund X, L.P. 9.4% $36,215,266 4,120,053 ARCH Venture Fund X, L.P. 31 Mar 2025
Deep Track Capital, LP 9.02% +30.1% $59,431,096 +$13,927,661 3,948,910 +30.6% Deep Track Capital, LP 30 Jun 2025
Frazier Life Sciences Public Fund, L.P. 7.7% -25% $50,461,371 -$16,531,281 3,352,915 -24.7% Frazier Life Sciences Public Fund, L.P. 30 Jun 2025
JANUS HENDERSON GROUP PLC 7.3% +21.7% $83,143,819 +$15,075,261 3,206,472 +22.1% JANUS HENDERSON GROUP PLC 30 Sep 2025
GV 2019, L.P. 5.5% $21,205,620 2,412,471 Alphabet Holdings LLC 31 Mar 2025
Matrix Capital Management Company, LP 3.5% -36.7% $42,880,026 -$21,586,725 1,653,684 -33.5% Matrix Capital Management Company, LP 30 Sep 2025
Foresite Capital Fund IV, L.P. 1.4% -70% $15,790,022 -$47,922,789 608,948 -75.2% James Tananbaum 30 Sep 2025

Institutional Holders of Maze Therapeutics, Inc. - Common Stock, par value $0.001 (MAZE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 42,970,633 $1,114,223,528 +$108,250,260 $25.93 93
2025 Q2 38,836,437 $476,719,891 -$14,337,293 $12.27 74
2025 Q1 40,038,674 $441,393,439 +$441,263,796 $11.01 68